γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US7033589B1 · kind B1 · utility
28Cited by
14References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 1999 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | Apr 14, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for inhibiting production of IgE in a human subject with an IgE-mediated allergic disorder by administering anti-CD23 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.